ADIPOQ and diabetic kidney disease: Urinary adiponectin has been thought to be excreted due to either disruption of the glomerular barrier8–10, tubular injuries8,12 or vascular damages13, and it is of interest to investigate if urinary adiponectin would have significance as a biomarker over other conventional biomarkers in diabetic kidney disease (DKD).